Compounds > 4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide
Page last updated: 2024-09-04

4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide and Arrhythmias, Cardiac

4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide has been researched along with Arrhythmias, Cardiac in 2 studies

*Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Funck-Brentano, C; Lineberry, MD; Pavlou, HN; Roden, DM; Woosley, RL1
Brown, BS; Calzadilla, SV; Diemer, MJ; Hartman, JC; Reynolds, RD1

Trials

1 trial(s) available for 4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide and Arrhythmias, Cardiac

ArticleYear
Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug.
    Clinical pharmacology and therapeutics, 1991, Volume: 49, Issue:3

    Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrrolidines; Time Factors; Ventricular Function

1991

Other Studies

1 other study(ies) available for 4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide and Arrhythmias, Cardiac

ArticleYear
Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Dogs; Electrocardiography; Female; Heart Conduction System; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Myocardial Contraction; Pyrrolidines

1987